If you qualify for the trial, you will visit a clinical research site in your area.
The Idiopathic Pulmonary Fibrosis Trial is assessing the potential for an investigational medication to reduce cough for people living with idiopathic pulmonary fibrosis (IPF). Volunteers who qualify to take part in the trial may receive compensation for time and travel expenses.
You may be eligible to take part in the Idiopathic Pulmonary Fibrosis Trial if you:
All trial-related care will be provided by a team of medical professionals.
Idiopathic Pulmonary Fibrosis (IPF) is a progressive, life-threatening disease that is characterized anatomically by scarring of the lungs and symptomatically by exertional dyspnea (shortness of breath) and dry cough.
IPF is a form of interstitial lung disease that involves the tissue and space around the air sacs of the lungs (called the interstitium)1. Over time, the scarring of the lungs gets worse and it becomes hard to take in a deep breath and the lungs cannot take in enough oxygen. This may result in a variety of symptoms including:
Unfortunately, the cause of idiopathic pulmonary fibrosis is not completely understood. "Idiopathic" means of unknown cause, therefore the science and medical community is still researching risk factors and causes for IPF. Common risk factors for Idiopathic Pulmonary Fibrosis include:
The Idiopathic Pulmonary Fibrosis Trial is assessing the potential for an investigational medication to reduce cough for people living with idiopathic pulmonary fibrosis (IPF).
If you choose to participate in the Idiopathic Pulmonary Fibrosis Trial you will visit a clinical research site in your area. At these visits you will undergo health assessments, medical questionnaires and physical examinations.
All trial-related care is provided at no cost to you. You do not need health insurance to participate.
Volunteers who take part in the trial may be eligible to receive compensation for study participation.
A Clinical Trial is a medical study that helps to answer important questions about an investigational drug or device. For example, is the drug or device effective? How does it compare with other drugs or devices?
All medications must be tested in clinical research trials before they can be approved by regulatory authorities for doctors to prescribe to patients. Without people taking part in these trials, we would have no new treatments. The volunteers who participate in clinical research trials play a major role in helping to advance medicine.
There is no cost to participate in the Idiopathic Pulmonary Fibrosis Trial. If you qualify, the investigational drug, trial-related tests, assessments, and visits will be provided to you at no cost. You will receive trial-related care throughout the trial from a team of medical professionals.
Volunteers who take part in the trial may be compensated for study participation. Please discuss this with the trial team when they contact you.
What happens if I Sign Up? If you think you might like to participate in the Idiopathic Pulmonary Fibrosis Trial or would like more information, please enter your information below so we can see if you may qualify and can contact you about the trial. Keep in mind that participation is entirely voluntary. If you do decide to take part in a trial, you may change your mind about participating at any time.
If you qualify, we will match you to a clinical research site in your area that is seeking participants or notify you if one becomes available. They will contact you to explain more about the trial before you make your decision about participating. You will attend an in-person visit where the trial team will help determine if you qualify and if the trial is right for you.